Nikoleta Juretic
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 07, 2025
Germline analysis of an international cohort of pediatric diffuse midline glioma patients.
Journal: Neuro-oncology
Published: March 12, 2025
3D genome topology distinguishes molecular subgroups of medulloblastoma.
Journal: American journal of human genetics
Published: June 10, 2024
Immune landscape of oncohistone-mutant gliomas reveals diverse myeloid populations and tumor-promoting function.
Journal: Nature communications
Published: November 14, 2023
Detection and genomic analysis of BRAF fusions in Juvenile Pilocytic Astrocytoma through the combination and integration of multi-omic data.
Journal: BMC cancer
Published: July 26, 2022
The Spruce Budworm Genome: Reconstructing the Evolutionary History of Antifreeze Proteins.
Journal: Genome biology and evolution
Published: April 04, 2022
TULIPs decorate the three-dimensional genome of PFA ependymoma.
Journal: Cell
Published: August 27, 2021
Histone H3.3 G34 mutations promote aberrant PRC2 activity and drive tumor progression.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 17, 2020
Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis.
Journal: Cell
Published: July 29, 2020
H3 K27M and EZHIP Impede H3K27-Methylation Spreading by Inhibiting Allosterically Stimulated PRC2.
Journal: Molecular cell
Published: June 08, 2020
PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism.
Journal: Nature communications
Published: January 03, 2019
Last Updated: 09/26/2026